⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21238891 | 0.76 | — | — | |
| SCHEMBL1645735 | 0.65 | — | — | |
| SCHEMBL4618903 | 0.64 | — | — | |
| SCHEMBL20609997 | 0.62 | TSHR (0.36) | — | |
| SCHEMBL19723582 | 0.62 | — | — | |
| SCHEMBL24335849 | 0.59 | — | — | |
| SCHEMBL23600285 | 0.59 | — | — | |
| SCHEMBL21140932 | 0.59 | — | — | |
| SCHEMBL5857513 | 0.58 | — | — | |
| SCHEMBL24497 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200039943-A1 | COMPOUNDS, DEVICES, AND USES THEREOF | SIGILON THERAPEUTICS, INC. | 2020-02-06 | — | — | US | disclosed |